Gynecologic Cancer Intergroup (GCIG) consensus review for ovarian germ cell tumors.
Identifieur interne : 003868 ( Main/Exploration ); précédent : 003867; suivant : 003869Gynecologic Cancer Intergroup (GCIG) consensus review for ovarian germ cell tumors.
Auteurs : Jubilee Brown [Royaume-Uni] ; Michael Friedlander ; Floor J. Backes ; Philipp Harter ; Dennis M. O'Connor ; Thibault De La Motte Rouge ; Domenica Lorusso ; Johanne Maenpaa ; Jae-Weon Kim ; Meghan E. Tenney ; Michael J. SecklSource :
- International journal of gynecological cancer : official journal of the International Gynecological Cancer Society [ 1525-1438 ] ; 2014.
Descripteurs français
- KwdFr :
- Adolescent, Association thérapeutique, Consensus, Femelle, Guides de bonnes pratiques cliniques comme sujet, Humains, Oncologie médicale, Sociétés médicales, Tumeurs de l'ovaire (), Tumeurs de l'ovaire (anatomopathologie), Tumeurs embryonnaires et germinales (), Tumeurs embryonnaires et germinales (anatomopathologie).
- MESH :
English descriptors
- KwdEn :
- MESH :
Abstract
Most women diagnosed with malignant ovarian germ cell tumors have curable disease and experience excellent survival with manageable treatment-associated morbidity, related both to tumor biology and improvements in treatment over the last 4 decades. Malignant ovarian germ cell tumors occur predominantly in girls, adolescents, and young women and are often unilateral tumors of early stage, although advanced-stage disease occurs in approximately 30% of patients. Tumors are usually chemosensitive, thereby allowing fertility-sparing surgery in most women with high chance of cure. Differences in practice do exist among providers in various subspecialties and geographic areas. In most settings, collaborative efforts among specialties allow the optimal treatment of women with these rare tumors, and implementation of standard guidelines at an international level should translate to effective clinical trial design, rapid accrual to clinical trials, and universally improved patient outcomes. This consensus guideline represents a summary of recommendations for diagnosis and management that has been agreed upon by cooperative groups worldwide. It builds upon individual publications including previously published summary documents and provides the most current practice standards validated worldwide.
DOI: 10.1097/IGC.0000000000000223
PubMed: 25341580
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 003340
- to stream PubMed, to step Curation: 003229
- to stream PubMed, to step Checkpoint: 003229
- to stream Ncbi, to step Merge: 001F30
- to stream Ncbi, to step Curation: 001F30
- to stream Ncbi, to step Checkpoint: 001F30
- to stream Main, to step Merge: 003903
- to stream Main, to step Curation: 003868
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Gynecologic Cancer Intergroup (GCIG) consensus review for ovarian germ cell tumors.</title><author><name sortKey="Brown, Jubilee" sort="Brown, Jubilee" uniqKey="Brown J" first="Jubilee" last="Brown">Jubilee Brown</name><affiliation wicri:level="3"><nlm:affiliation>*University of Texas MD Anderson Cancer Center, Houston, TX (Gynecologic Oncology Group [GOG]); †Prince of Wales Hospital, Sydney, Australia (Australia and New Zealand Gynecological Oncology Group [ANZGOG]); ‡The Ohio State University, Columbus, OH (GOG); §Kliniken Essen-Mitte, Essen, Germany (AGO); ∥University of Louisville, Louisville, KY (GOG); ¶Institut Curie, Hôpital Rene Huguenin, Saint Cloud, France (Group d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens [GINECO]); #Fondazione IRCCS National Cancer Institute of Milan, Italy (Multicentre Italian Trials in Ovarian Cancer); **Tampere University Hospital, Tampere, Finland (Nordic Society of Gynaecological Oncology); ††Seoul National University College of Medicine, Seoul, Korea (Korean Gynecologic Oncology Group); ‡‡The University of Chicago, Chicago, IL (GOG); and §§Charing Cross Hospital, London, UK (Medical Research Council/National Cancer Research Institute [MRC NCRI]).</nlm:affiliation><country>Royaume-Uni</country><wicri:regionArea>*University of Texas MD Anderson Cancer Center, Houston, TX (Gynecologic Oncology Group [GOG]); †Prince of Wales Hospital, Sydney, Australia (Australia and New Zealand Gynecological Oncology Group [ANZGOG]); ‡The Ohio State University, Columbus, OH (GOG); §Kliniken Essen-Mitte, Essen, Germany (AGO); ∥University of Louisville, Louisville, KY (GOG); ¶Institut Curie, Hôpital Rene Huguenin, Saint Cloud, France (Group d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens [GINECO]); #Fondazione IRCCS National Cancer Institute of Milan, Italy (Multicentre Italian Trials in Ovarian Cancer); **Tampere University Hospital, Tampere, Finland (Nordic Society of Gynaecological Oncology); ††Seoul National University College of Medicine, Seoul, Korea (Korean Gynecologic Oncology Group); ‡‡The University of Chicago, Chicago, IL (GOG); and §§Charing Cross Hospital, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author><author><name sortKey="Friedlander, Michael" sort="Friedlander, Michael" uniqKey="Friedlander M" first="Michael" last="Friedlander">Michael Friedlander</name></author><author><name sortKey="Backes, Floor J" sort="Backes, Floor J" uniqKey="Backes F" first="Floor J" last="Backes">Floor J. Backes</name></author><author><name sortKey="Harter, Philipp" sort="Harter, Philipp" uniqKey="Harter P" first="Philipp" last="Harter">Philipp Harter</name></author><author><name sortKey="O Connor, Dennis M" sort="O Connor, Dennis M" uniqKey="O Connor D" first="Dennis M" last="O'Connor">Dennis M. O'Connor</name></author><author><name sortKey="De La Motte Rouge, Thibault" sort="De La Motte Rouge, Thibault" uniqKey="De La Motte Rouge T" first="Thibault" last="De La Motte Rouge">Thibault De La Motte Rouge</name></author><author><name sortKey="Lorusso, Domenica" sort="Lorusso, Domenica" uniqKey="Lorusso D" first="Domenica" last="Lorusso">Domenica Lorusso</name></author><author><name sortKey="Maenpaa, Johanne" sort="Maenpaa, Johanne" uniqKey="Maenpaa J" first="Johanne" last="Maenpaa">Johanne Maenpaa</name></author><author><name sortKey="Kim, Jae Weon" sort="Kim, Jae Weon" uniqKey="Kim J" first="Jae-Weon" last="Kim">Jae-Weon Kim</name></author><author><name sortKey="Tenney, Meghan E" sort="Tenney, Meghan E" uniqKey="Tenney M" first="Meghan E" last="Tenney">Meghan E. Tenney</name></author><author><name sortKey="Seckl, Michael J" sort="Seckl, Michael J" uniqKey="Seckl M" first="Michael J" last="Seckl">Michael J. Seckl</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2014">2014</date><idno type="RBID">pubmed:25341580</idno><idno type="pmid">25341580</idno><idno type="doi">10.1097/IGC.0000000000000223</idno><idno type="wicri:Area/PubMed/Corpus">003340</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">003340</idno><idno type="wicri:Area/PubMed/Curation">003229</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">003229</idno><idno type="wicri:Area/PubMed/Checkpoint">003229</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">003229</idno><idno type="wicri:Area/Ncbi/Merge">001F30</idno><idno type="wicri:Area/Ncbi/Curation">001F30</idno><idno type="wicri:Area/Ncbi/Checkpoint">001F30</idno><idno type="wicri:Area/Main/Merge">003903</idno><idno type="wicri:Area/Main/Curation">003868</idno><idno type="wicri:Area/Main/Exploration">003868</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Gynecologic Cancer Intergroup (GCIG) consensus review for ovarian germ cell tumors.</title><author><name sortKey="Brown, Jubilee" sort="Brown, Jubilee" uniqKey="Brown J" first="Jubilee" last="Brown">Jubilee Brown</name><affiliation wicri:level="3"><nlm:affiliation>*University of Texas MD Anderson Cancer Center, Houston, TX (Gynecologic Oncology Group [GOG]); †Prince of Wales Hospital, Sydney, Australia (Australia and New Zealand Gynecological Oncology Group [ANZGOG]); ‡The Ohio State University, Columbus, OH (GOG); §Kliniken Essen-Mitte, Essen, Germany (AGO); ∥University of Louisville, Louisville, KY (GOG); ¶Institut Curie, Hôpital Rene Huguenin, Saint Cloud, France (Group d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens [GINECO]); #Fondazione IRCCS National Cancer Institute of Milan, Italy (Multicentre Italian Trials in Ovarian Cancer); **Tampere University Hospital, Tampere, Finland (Nordic Society of Gynaecological Oncology); ††Seoul National University College of Medicine, Seoul, Korea (Korean Gynecologic Oncology Group); ‡‡The University of Chicago, Chicago, IL (GOG); and §§Charing Cross Hospital, London, UK (Medical Research Council/National Cancer Research Institute [MRC NCRI]).</nlm:affiliation><country>Royaume-Uni</country><wicri:regionArea>*University of Texas MD Anderson Cancer Center, Houston, TX (Gynecologic Oncology Group [GOG]); †Prince of Wales Hospital, Sydney, Australia (Australia and New Zealand Gynecological Oncology Group [ANZGOG]); ‡The Ohio State University, Columbus, OH (GOG); §Kliniken Essen-Mitte, Essen, Germany (AGO); ∥University of Louisville, Louisville, KY (GOG); ¶Institut Curie, Hôpital Rene Huguenin, Saint Cloud, France (Group d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens [GINECO]); #Fondazione IRCCS National Cancer Institute of Milan, Italy (Multicentre Italian Trials in Ovarian Cancer); **Tampere University Hospital, Tampere, Finland (Nordic Society of Gynaecological Oncology); ††Seoul National University College of Medicine, Seoul, Korea (Korean Gynecologic Oncology Group); ‡‡The University of Chicago, Chicago, IL (GOG); and §§Charing Cross Hospital, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author><author><name sortKey="Friedlander, Michael" sort="Friedlander, Michael" uniqKey="Friedlander M" first="Michael" last="Friedlander">Michael Friedlander</name></author><author><name sortKey="Backes, Floor J" sort="Backes, Floor J" uniqKey="Backes F" first="Floor J" last="Backes">Floor J. Backes</name></author><author><name sortKey="Harter, Philipp" sort="Harter, Philipp" uniqKey="Harter P" first="Philipp" last="Harter">Philipp Harter</name></author><author><name sortKey="O Connor, Dennis M" sort="O Connor, Dennis M" uniqKey="O Connor D" first="Dennis M" last="O'Connor">Dennis M. O'Connor</name></author><author><name sortKey="De La Motte Rouge, Thibault" sort="De La Motte Rouge, Thibault" uniqKey="De La Motte Rouge T" first="Thibault" last="De La Motte Rouge">Thibault De La Motte Rouge</name></author><author><name sortKey="Lorusso, Domenica" sort="Lorusso, Domenica" uniqKey="Lorusso D" first="Domenica" last="Lorusso">Domenica Lorusso</name></author><author><name sortKey="Maenpaa, Johanne" sort="Maenpaa, Johanne" uniqKey="Maenpaa J" first="Johanne" last="Maenpaa">Johanne Maenpaa</name></author><author><name sortKey="Kim, Jae Weon" sort="Kim, Jae Weon" uniqKey="Kim J" first="Jae-Weon" last="Kim">Jae-Weon Kim</name></author><author><name sortKey="Tenney, Meghan E" sort="Tenney, Meghan E" uniqKey="Tenney M" first="Meghan E" last="Tenney">Meghan E. Tenney</name></author><author><name sortKey="Seckl, Michael J" sort="Seckl, Michael J" uniqKey="Seckl M" first="Michael J" last="Seckl">Michael J. Seckl</name></author></analytic><series><title level="j">International journal of gynecological cancer : official journal of the International Gynecological Cancer Society</title><idno type="eISSN">1525-1438</idno><imprint><date when="2014" type="published">2014</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent</term><term>Combined Modality Therapy</term><term>Consensus</term><term>Female</term><term>Humans</term><term>Medical Oncology</term><term>Neoplasms, Germ Cell and Embryonal (pathology)</term><term>Neoplasms, Germ Cell and Embryonal (therapy)</term><term>Ovarian Neoplasms (pathology)</term><term>Ovarian Neoplasms (therapy)</term><term>Practice Guidelines as Topic</term><term>Societies, Medical</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adolescent</term><term>Association thérapeutique</term><term>Consensus</term><term>Femelle</term><term>Guides de bonnes pratiques cliniques comme sujet</term><term>Humains</term><term>Oncologie médicale</term><term>Sociétés médicales</term><term>Tumeurs de l'ovaire ()</term><term>Tumeurs de l'ovaire (anatomopathologie)</term><term>Tumeurs embryonnaires et germinales ()</term><term>Tumeurs embryonnaires et germinales (anatomopathologie)</term></keywords><keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Tumeurs de l'ovaire</term><term>Tumeurs embryonnaires et germinales</term></keywords><keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Neoplasms, Germ Cell and Embryonal</term><term>Ovarian Neoplasms</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Neoplasms, Germ Cell and Embryonal</term><term>Ovarian Neoplasms</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adolescent</term><term>Combined Modality Therapy</term><term>Consensus</term><term>Female</term><term>Humans</term><term>Medical Oncology</term><term>Practice Guidelines as Topic</term><term>Societies, Medical</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adolescent</term><term>Association thérapeutique</term><term>Consensus</term><term>Femelle</term><term>Guides de bonnes pratiques cliniques comme sujet</term><term>Humains</term><term>Oncologie médicale</term><term>Sociétés médicales</term><term>Tumeurs de l'ovaire</term><term>Tumeurs embryonnaires et germinales</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Most women diagnosed with malignant ovarian germ cell tumors have curable disease and experience excellent survival with manageable treatment-associated morbidity, related both to tumor biology and improvements in treatment over the last 4 decades. Malignant ovarian germ cell tumors occur predominantly in girls, adolescents, and young women and are often unilateral tumors of early stage, although advanced-stage disease occurs in approximately 30% of patients. Tumors are usually chemosensitive, thereby allowing fertility-sparing surgery in most women with high chance of cure. Differences in practice do exist among providers in various subspecialties and geographic areas. In most settings, collaborative efforts among specialties allow the optimal treatment of women with these rare tumors, and implementation of standard guidelines at an international level should translate to effective clinical trial design, rapid accrual to clinical trials, and universally improved patient outcomes. This consensus guideline represents a summary of recommendations for diagnosis and management that has been agreed upon by cooperative groups worldwide. It builds upon individual publications including previously published summary documents and provides the most current practice standards validated worldwide.</div></front></TEI><affiliations><list><country><li>Royaume-Uni</li></country><region><li>Angleterre</li><li>Grand Londres</li></region><settlement><li>Londres</li></settlement></list><tree><noCountry><name sortKey="Backes, Floor J" sort="Backes, Floor J" uniqKey="Backes F" first="Floor J" last="Backes">Floor J. Backes</name><name sortKey="De La Motte Rouge, Thibault" sort="De La Motte Rouge, Thibault" uniqKey="De La Motte Rouge T" first="Thibault" last="De La Motte Rouge">Thibault De La Motte Rouge</name><name sortKey="Friedlander, Michael" sort="Friedlander, Michael" uniqKey="Friedlander M" first="Michael" last="Friedlander">Michael Friedlander</name><name sortKey="Harter, Philipp" sort="Harter, Philipp" uniqKey="Harter P" first="Philipp" last="Harter">Philipp Harter</name><name sortKey="Kim, Jae Weon" sort="Kim, Jae Weon" uniqKey="Kim J" first="Jae-Weon" last="Kim">Jae-Weon Kim</name><name sortKey="Lorusso, Domenica" sort="Lorusso, Domenica" uniqKey="Lorusso D" first="Domenica" last="Lorusso">Domenica Lorusso</name><name sortKey="Maenpaa, Johanne" sort="Maenpaa, Johanne" uniqKey="Maenpaa J" first="Johanne" last="Maenpaa">Johanne Maenpaa</name><name sortKey="O Connor, Dennis M" sort="O Connor, Dennis M" uniqKey="O Connor D" first="Dennis M" last="O'Connor">Dennis M. O'Connor</name><name sortKey="Seckl, Michael J" sort="Seckl, Michael J" uniqKey="Seckl M" first="Michael J" last="Seckl">Michael J. Seckl</name><name sortKey="Tenney, Meghan E" sort="Tenney, Meghan E" uniqKey="Tenney M" first="Meghan E" last="Tenney">Meghan E. Tenney</name></noCountry><country name="Royaume-Uni"><region name="Angleterre"><name sortKey="Brown, Jubilee" sort="Brown, Jubilee" uniqKey="Brown J" first="Jubilee" last="Brown">Jubilee Brown</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003868 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003868 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:25341580
|texte= Gynecologic Cancer Intergroup (GCIG) consensus review for ovarian germ cell tumors.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:25341580" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a AustralieFrV1
| This area was generated with Dilib version V0.6.33. |  |